Raja Kumaraguru
Stock Analyst at Roth MKM
(n/a)
# 4,821
Out of 4,876 analysts
5
Total ratings
n/a
Success rate
-43.92%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Raja Kumaraguru
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RAIN Rain Enhancement Technologies Holdco | Downgrades: Neutral | $1.2 | $3.33 | -63.96% | 1 | May 30, 2023 | |
| NLSP NLS Pharmaceutics AG | Initiates: Buy | $480 | $2.79 | +17,104.30% | 1 | Mar 12, 2021 | |
| CNSP CNS Pharmaceuticals | Initiates: Buy | $750,000 | $0.88 | +85,324,132.08% | 1 | Feb 2, 2021 | |
| FBRX Forte Biosciences | Initiates: Buy | $2,250 | $12.25 | +18,267.35% | 1 | Aug 28, 2020 | |
| MNPR Monopar Therapeutics | Initiates: Buy | $210 | $33.60 | +525.00% | 1 | Feb 19, 2020 |
Rain Enhancement Technologies Holdco
May 30, 2023
Downgrades: Neutral
Price Target: $1.2
Current: $3.33
Upside: -63.96%
NLS Pharmaceutics AG
Mar 12, 2021
Initiates: Buy
Price Target: $480
Current: $2.79
Upside: +17,104.30%
CNS Pharmaceuticals
Feb 2, 2021
Initiates: Buy
Price Target: $750,000
Current: $0.88
Upside: +85,324,132.08%
Forte Biosciences
Aug 28, 2020
Initiates: Buy
Price Target: $2,250
Current: $12.25
Upside: +18,267.35%
Monopar Therapeutics
Feb 19, 2020
Initiates: Buy
Price Target: $210
Current: $33.60
Upside: +525.00%